ArticleAJOG global reports2026
Predicting lifetime cervical cancer screening among sexually active women in low- and middle-income countries using machine learning models: evidence from Demographic and Health Surveys.
Article in AJOG global reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCervical cancer poses a major health risk in low- and middle-income countries (LMICs), with high morbidity and mortality among women. It is largely preventable through screening and early treatment, but underused programs lead to a heavy burden. The goal is to identify key factors influencing screening, reveal inequities, and improve policies in resource-limited areas.
methodsUsing recent Demographic and Health Surveys (DHS) data from 19 LMICs, this study estimated lifetime cervical cancer screening among women aged 15 to 49 years. Missing data were removed, and class balancing was performed with synthetic minority oversampling technique. GridSearch optimized hyperparameters before dividing data into training and validation sets. Multiple machine learning algorithms predicted lifetime screening, including decision trees, random forests, gradient boosting, extra trees, XGBoost, LightGBM, and catBoost classifiers. Model performance was evaluated using accuracy, recall, precision, F1 score, and receiver operating characteristics area under the curve.
resultsThe analysis of 261,371 women aged 15 to 49 from the DHS found that random forest achieved 80% accuracy, 87% precision, 80% recall, and an 80% F1 score, while extra trees achieved 79%, 87%, 79%, and 83%. Key predictors included household size, wealth, women's age, and education. Ensemble methods such as random forests and extra trees demonstrated strong generalization, making them useful for targeted interventions.
conclusionEnsemble algorithms such as random forests and extra trees predict lifetime cervical cancer screening with ∼80% accuracy in LMICS. The study emphasizes targeted awareness, education, and age-sensitive screening. Findings will be tested in other populations to support clinical decision systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.